[Our experience in the treatment of reflux esophagitis with histamine H2 receptor antagonists].
The object of this study was to value the efficacy of reflux oesophagitis treatment by H2-blockers. Fifty-one patients were treated by Cimetidine or Ranitidine. After three months, we note a clinical improvement in 84% of cases and a regression of the endoscopic lesions in 61% of cases. A long term overlooking shows a high number of recurrences when the treatment is stopped, whereas the chronic treatment has essentially a stabilizing effect on the lesions.
D000328:Adult; D000368:Aged; D002927:Cimetidine / Q000008:administration & dosage*; D004341:Drug Evaluation; D004942:Esophagitis, Peptic / Q000175:diagnosis / Q000188:drug therapy*; D004945:Esophagoscopy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011899:Ranitidine / Q000008:administration & dosage*
D002927:Cimetidine; D011899:Ranitidine
Notre expérience du traitement de l'oesophagite de reflux par les antagonistes des récepteurs H2.